Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
06/16/1993 | EP0546055A1 Polyethylene glycol derivatives for solid-phase applications. |
06/16/1993 | EP0545946A1 Growth-promoting agent |
06/16/1993 | EP0406259B1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours |
06/16/1993 | EP0391974B1 Process for the purification of vitamin k-dependent blood clotting factors |
06/16/1993 | EP0308500B1 Human somatomedin carrier protein subunits and process for producing them |
06/16/1993 | CN1073208A Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
06/16/1993 | CN1073180A Producing technology for pineapple seed agglutinin |
06/15/1993 | US5219999 Immunoglobulin g and process for the production thereof |
06/15/1993 | US5219996 Recombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor molecules |
06/15/1993 | US5219995 Activating Factor II to Factor IIa using Factor Va and Factor Xa, wherein Factors II, Va, and Xa are all derived from a single impure protein fraction |
06/15/1993 | US5219993 Method of recovering purified epi protein from a solution especially a fermentation solution |
06/15/1993 | US5219988 Gem-diamino derivatives and their use in the synthesis of retro-inverso peptides |
06/15/1993 | US5219749 Process for isolating and preparing purified chitin deacetylase |
06/15/1993 | US5219732 Antibody-mediated cofactor-driven reactions |
06/10/1993 | WO1993011436A1 C-terminal peptide sequencing using diphenyl phosphoroisothiocyanatidate and pyridine |
06/10/1993 | WO1993011248A1 Production of proteins using 7b2 protein |
06/10/1993 | WO1993011240A1 Method for refolding igf-i to active conformation |
06/10/1993 | WO1993011231A1 Tools for the diagnosis and treatment of alzheimer's disease |
06/10/1993 | WO1993011161A1 Multivalent antigen-binding proteins |
06/10/1993 | WO1993011152A1 New peptide derivatives |
06/10/1993 | WO1993010811A1 Proteolytic mixture containing escharase and method of isolating same |
06/10/1993 | WO1993010807A1 Hemoregulatory peptides |
06/10/1993 | CA2125298A1 Tools for the diagnosis and treatment of alzheimer's disease |
06/10/1993 | CA2124202A1 Hemoregulatory peptides |
06/10/1993 | CA2123567A1 Production of proteins using 7b2 protein |
06/10/1993 | CA2101449A1 C-terminal peptide sequencing using diphenyl phosphoroisothiocyanatidate and pyridine |
06/09/1993 | EP0544706A1 Histidine substituted growth hormone releasing factor analogs |
06/09/1993 | EP0495096A4 Plant fatty acid synthases |
06/09/1993 | EP0368920B1 Lectines fixing beta-d-galactoside |
06/08/1993 | US5218092 Stability |
06/08/1993 | US5217705 Method of diagnosing blood clots using fibrin-binding proteins |
06/08/1993 | CA1318869C Method of removing n-terminal amino acid residues from eucaryotic polypeptide analogs and polypeptides produced thereby |
06/06/1993 | CA2057087A1 Composition and method for isolation and purification of immunoglobulin m |
06/03/1993 | DE4139639A1 Synthetic aq. organ extract free of contaminating proteins etc. - contains aminoacid(s) peptide(s), sugar alcohol, carboxylic acid and alcohol, useful e.g. in cosmetics, for wound healing and to strengthen immunity |
06/02/1993 | EP0544620A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP) |
06/02/1993 | EP0544525A2 An apparatus for generating a constraint condition in a molecular dynamics method |
06/02/1993 | EP0544293A2 Process for the preparation of biologically active NGF by genetic engineering |
06/01/1993 | US5216133 Thermosensitive, trypsin, chymotrypsin and mercaptam sensitive, pure protein |
06/01/1993 | US5216129 Production of kappa-caseino-glycomacropeptide |
06/01/1993 | US5216128 IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it |
06/01/1993 | US5215967 Aminoacid derivatives inhibiting renin |
06/01/1993 | US5215966 For treatment of hypertension, hyperaldosteronism and cardiac insufficiency |
06/01/1993 | CA1318751C Process for producing stable -l-aspartyl-l- phenylalanine methyl ester |
06/01/1993 | CA1318626C Method for preparative expression of genes in cell-free system of conjugated transcription/translation |
06/01/1993 | CA1318615C Radiohalogenated compounds for site specific labeling |
05/27/1993 | WO1993010233A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor |
05/27/1993 | WO1993010161A1 Polymer reversal on solid surfaces |
05/27/1993 | WO1993010152A1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG |
05/27/1993 | WO1993010144A1 New endothelin antagonists and their preparation |
05/27/1993 | WO1993009872A1 Test device comprising a plate containing a multiplicity of wells with an associated metering device, as well as a kit which comprises these devices and use of the devices |
05/27/1993 | WO1993009869A1 Adsorbent for blood coagulation factor viii |
05/27/1993 | WO1993009810A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
05/27/1993 | WO1993009806A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality |
05/27/1993 | WO1993009668A1 Combinatorial strategies for polymer synthesis |
05/27/1993 | WO1993003058A3 Non-desensitizing analogs of gnrh and other biologically active ligands |
05/27/1993 | CA2389355A1 Combinatorial strategies for polymer synthesis |
05/27/1993 | CA2123801A1 Test device comprising a plate containing a multiplicity of wells with an associated metering device, as well as a kit which comprises these devices and use of the devices |
05/27/1993 | CA2123395A1 New endothelin antagonists and their preparation |
05/27/1993 | CA2123234A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor |
05/27/1993 | CA2123228A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
05/27/1993 | CA2083622A1 Certain macrocyclic lactam derivatives |
05/26/1993 | EP0543521A2 High dosage topical forms of collagenase |
05/26/1993 | EP0543195A2 Biosynthetic process for the preparation of proteins |
05/26/1993 | EP0542971A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY |
05/26/1993 | EP0542937A1 Growth hormone releasing factor analogs |
05/26/1993 | EP0542790A1 Method and kit for the separation, concentration and analysis of cells |
05/26/1993 | EP0542770A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
05/26/1993 | EP0167575B1 Cardiodilatine, a new peptide hormone and production process thereof |
05/25/1993 | US5214195 Allyl esters and the use thereof for the build-up of solid phase systems for solid phase reactions |
05/25/1993 | US5214132 Polypeptide derivatives of human granulocyte colony stimulating factor |
05/25/1993 | US5214131 Polyethylene glycol derivatives, modified peptides and production thereof |
05/25/1993 | CA1318462C Synthetic resin |
05/25/1993 | CA1318461C Tripeptide derivatives |
05/25/1993 | CA1318459C Imides, a process for their production thereof and a process for the production of dipeptides by using them |
05/25/1993 | CA1318458C Preparation process of -l-aspartyl-l-phenyl-alanine methyl ester having low hygroscopicity |
05/25/1993 | CA1318457C Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them |
05/25/1993 | CA1318456C Peptides |
05/19/1993 | EP0542314A1 Formation of protein microparticles by antisolvent precipitation |
05/19/1993 | EP0542145A1 Oligosaccharides with antigenic determinants from the jelly coat of amphibian eggs |
05/19/1993 | EP0541822A1 Novel calcitonin, and production and use thereof |
05/19/1993 | EP0541726A1 Growth factor compositions, preparation and use |
05/19/1993 | EP0541691A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
05/19/1993 | EP0541654A1 Bombesin antagonists |
05/19/1993 | EP0541645A1 Method of purifying cytokeratin 20, and the use of cytokeratin 20 to produce antibodies |
05/19/1993 | EP0541556A1 Stabilization of biological macromolecular substances and other organic compounds |
05/19/1993 | EP0390821B1 Process for extracting pure fractions of lactoperoxidase and lactoferrin from milk serum |
05/18/1993 | US5212288 Temporary minimal protection synthesis of serine-containing polypeptides |
05/18/1993 | US5212235 Hydrophobically modified proteins |
05/18/1993 | US5212158 Nootropic agents |
05/18/1993 | US5212157 Tetrapeptides as inhibitors of HIV |
05/18/1993 | US5212072 Genetic engineering and DNA sequences |
05/18/1993 | CA1317899C Stabilization of antibodies |
05/13/1993 | WO1993009234A2 Suppressor and progenitor cells |
05/13/1993 | WO1993009231A1 Novel thrombin-inhibiting protein from ticks |
05/13/1993 | WO1993009143A1 Production and use of multimeric hemoglobins |
05/13/1993 | WO1993009136A1 Phosphonopeptides with collagenase inhibiting activity |
05/13/1993 | WO1993009135A1 Peptides inhibiting il-1 beta release |
05/13/1993 | WO1993009132A1 Hiv protease inhibitors containing guanidine |
05/13/1993 | WO1993009131A1 Method for isolating immunoglobulin compounds in the feces |
05/13/1993 | WO1993009130A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |